The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Open accessAbstract
The proteasome inhibitor PS-341 inhibits IκB degradation, prevents NF-κB activation, and induces apoptosis in several types of cancer cells, including chemoresistant multiple myeloma (MM) cells. PS-341 has marked clinical activity even in the setting of relapsed refractory MM. However, PS-341-induced apoptotic cascade(s) are not yet fully defined. By using gene expression profiling, we characterized the molecular sequelae of PS-341 treatment in MM cells and further focused on molecular pathways responsible for the anticancer actions of this promising agent. The transcriptional profile of PS-341-treated cells involved down-regulation of growth/survival signaling pathways, and up-regulation of molecules implicated in proapoptotic cascades (which are both consistent with the proapoptotic effect of proteasome inhibition), as well as up-regulation of heat-shock proteins and ubiquitin/proteasome pathway members (which can correspond to stress responses against proteasome inhibition). Further studies on these pathways showed that PS-341 decreases the levels of several antiapoptotic proteins and triggers a dual apoptotic pathway of mitochondrial cytochrome c release and caspase-9 activation, as well as activation of Jun kinase and a Fas/caspase-8-dependent apoptotic pathway [which is inhibited by a dominant negative (decoy) Fas construct]. Stimulation with IGF-1, as well as overexpression of Bcl-2 or constitutively active Akt in MM cells also modestly attenuates PS-341-induced cell death, whereas inhibitors of the BH3 domain of Bcl-2 family members or the heat-shock protein 90 enhance tumor cell sensitivity to proteasome inhibition. These data provide both insight into the molecular mechanisms of antitumor activity of PS-341 and the rationale for future clinical trials of PS-341, in combination with conventional and novel therapies, to improve patient outcome in MM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9
Zou, H., Li, Y., Liu, X., & Wang, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11549 · Cited by 2,090
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Hideshima, T., Richardson, P. G. G., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & Anderson, K. C. (2001) · PubMed · Cited by 1,508
Self-citationProteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
NF-κB as a Therapeutic Target in Multiple Myeloma
Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200360200 · Cited by 893
Self-citationMitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N. C., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.12.4525 · Cited by 669
Self-citationIdentification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Varshavsky, A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01122-5 · Cited by 545
Ciechanover, A., Finley, D., & Varshavsky, A. (1984) · Cell · doi:10.1016/0092-8674(84)90300-3 · Cited by 533
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
Mitsiades, C. S., Mitsiades, N., Poulaki, V., Schlossman, R., Akiyama, M., Chauhan, D., Hideshima, T., Treon, S. P., Munshi, N. C., Richardson, P. G., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205664 · Cited by 464
Self-citationLeBlanc, R., Catley, L. P., Hideshima, T., Lentzsch, S., Mitsiades, C. S., Mitsiades, N., Neuberg, D. S., Goloubeva, O. G., Pien, C. S., Adams, J., et al. (2002) · PubMed · Cited by 450
Self-citationMitsiades, N., Yu, W., Poulaki, V., Tsokos, M., & Stamenkovic, I. (2001) · PubMed · Cited by 441
Self-citationInterferon-γ Induces Different Subunit Organizations and Functional Diversity of Proteasomes1
Aki, M., Shimbara, N., Takashina, M., Akiyama, K., Kagawa, S., Tamura, T., Tanahashi, N., Yoshimura, T., Tanaka, K., & Ichihara, A. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124327 · Cited by 398
Hideshima, T., Chauhan, D., Schlossman, R., Richardson, P., & Anderson, K. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204623 · Cited by 394
Self-citationMitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., & Anderson, K. C. (2001) · Blood · doi:10.1182/blood.v98.3.795 · Cited by 392
Self-citationRequirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis
Hueber, A.-O., Zörnig, M., Lyon, D., Suda, T., Nagata, S., & Evan, G. I. (1997) · Science · doi:10.1126/science.278.5341.1305 · Cited by 370
Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.11.4079 · Cited by 367
Self-citationProteasome Inhibitors Activate Stress Kinases and Induce Hsp72
Meriin, A. B., Gabai, V. L., Yaglom, J., Shifrin, V. I., & Sherman, M. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6373 · Cited by 300
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Basso, A. D., Solit, D. B., Munster, P. N., & Rosen, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205184 · Cited by 265
Ubiquitin as a degradation signal.
Johnson, E. S., Bartel, B., Seufert, W., & Varshavsky, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05080.x · Cited by 263
Lee, D. H., & Goldberg, A. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.30 · Cited by 231
A Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids
Wissink, S., van Heerde, E. C., van der Burg, B., & van der Saag, P. T. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0081 · Cited by 225
Toso, a Cell Surface, Specific Regulator of Fas-Induced Apoptosis in T Cells
Hitoshi, Y., Lorens, J., Kitada, S.-I., Fisher, J., LaBarge, M., Ring, H. Z., Francke, U., Reed, J. C., Kinoshita, S., & Nolan, G. P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80551-8 · Cited by 221
Chauhan, D., Hideshima, T., Rosen, S., Reed, J. C., Kharbanda, S., & Anderson, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100074200 · Cited by 202
Self-citationFleming, J. A., Lightcap, E. S., Sadis, S., Thoroddsen, V., Bulawa, C. E., & Blackman, R. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032516399 · Cited by 198
Sheikh, M. S., Hollander, M. C., & Fornace, A. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00291-9 · Cited by 196
Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma.
Hisamatsu, H., Shimbara, N., Saito, Y., Kristensen, P., Hendil, K. B., Fujiwara, T., Takahashi, E., Tanahashi, N., Tamura, T., Ichihara, A., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1807 · Cited by 195
cDNA Cloning and Interferon γ Down-Regulation of Proteasomal Aubunits X and Y
Akiyama, K.-Y., Yokota, K.-Y., Kagawa, S., Shimbara, N., Tamura, T., Akioka, H., Nothwang, H. G., Noda, C., Tanaka, K., & Ichihara, A. (1994) · Science · doi:10.1126/science.8066462 · Cited by 186
Münster, P. N., Basso, A., Solit, D., Norton, L., & Rosen, N. (2001) · PubMed · Cited by 173
Mammalian GADD34, an Apoptosis- and DNA Damage-inducible Gene
Hollander, M. C., Zhan, Q., Bae, I., & Fornace, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13731 · Cited by 168
Gaczynska, M., Goldberg, A. L., Tanaka, K., Hendil, K. B., & Rock, K. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17275 · Cited by 160
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Anderson, K. C., & Treon, S. P. (2002) · Blood · doi:10.1182/blood.v99.6.2162 · Cited by 159
Self-citationMünster, P. N., Srethapakdi, M., Moasser, M. M., & Rosen, N. X. (2001) · PubMed · Cited by 153
Akiyama, K., Kagawa, S., Tamura, T., Shimbara, N., Takashina, M., Kristensen, P., Hendil, K. B., Tanaka, K., & Ichihara, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80612-8 · Cited by 143
The myeloma cell antigen syndecan‐1 is lost by apoptotic myeloma cells
Jourdan, M., Ferlin, M., Legouffe, É., Horváthová, M., Liautard, J., Rossi, J. F., Wijdenes, J., Brochier, J., & Klein, B. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00623.x · Cited by 134
Flinn, E. M., Busch, C. M. C., & Wright, A. P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5961 · Cited by 131
Kominami, K., Demartino, G., Moomaw, C. R., Slaughter, C. A., Shimbara, N., Fujimuro, M., Yokosawa, H., Hisamatsu, H., Tanahashi, N., & Shimizu, Y. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07313.x · Cited by 94
Hori, T., Kato, S., Saeki, M., Demartino, G., Slaughter, C. A., Takeuchi, J. S., Toh‐e, A., & Tanaka, K. (1998) · Gene · doi:10.1016/s0378-1119(98)00309-6 · Cited by 90
Spataro, V. J., Toda, T., Craig, R., Seeger, M., Dubiel, W., Harris, A. L., & Norbury, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30470 · Cited by 85
Expression of Fas Ligand in Activated T Cells Is Regulated by c-Myc
Brunner, T., Kasibhatla, S., Pinkoski, M. J., Frutschi, C., Yoo, N. J., Echeverri, F., Mahboubi, A., & Green, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9767 · Cited by 83
Glucocorticoid-Induced Apoptosis and Regulation of NF- B Activity in Human Leukemic T Cells
Ramdas, J., & Harmon, J. M. (1998) · Endocrinology · doi:10.1210/endo.139.9.6180 · Cited by 83
Ogawa, M., Nishiura, T., Oritani, K., Yoshida, H., Yoshimura, M., Okajima, Y., Ishikawa, J., Hashimoto, K., Matsumura, I., Tomiyama, Y., et al. (2000) · PubMed · Cited by 74
Grishin, A., Azhipa, O., Semenov, I., & Corey, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191130798 · Cited by 73
Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases
Mitsiades, N., Poulaki, V., Mitsiades, C. S., Koutras, D. A., & Chrousos, G. P. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00441-6 · Cited by 66
Self-citationTsurumi, C., Shimizu, Y., Saeki, M., Kato, S., Demartino, G., Slaughter, C. A., Fujimuro, M., Yokosawa, H., Yamasaki, M., Hendil, K. B., et al. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0912u.x · Cited by 65
YOKOTA, K., Kagawa, S., Shimizu, Y., Akioka, H., Tsurumi, C., Noda, C., Fujimuro, M., Yokosawa, H., Fujiwara, T., Takahashi, E., et al. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.6.853 · Cited by 58
Li, X. R., Chong, A. S., Wu, J., Roebuck, K. A., Kumar, A., Parrillo, J. E., Rapp, U. R., Kimberly, R. P., Williams, J. W., & Xu, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35203 · Cited by 44
Tani, E., Kitagawa, H., Ikemoto, H., & Matsumoto, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02770-3 · Cited by 38
cDNA cloning and functional analysis of p44.5 and p55, two regulatory subunits of the 26S proteasome
Saito, A., Watanabe, T., Shimada, Y., Fujiwara, T., Slaughter, C. A., Demartino, G., Tanahashi, N., & Tanaka, K. (1997) · Gene · doi:10.1016/s0378-1119(97)00524-6 · Cited by 29
Targeting of proteins for degradation.
Varshavsky, A. J., Bachmair, A., Finley, D. J., Gonda, D. K., & Wünning, I. (1989) · PubMed · Cited by 15
Cited by
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Self-citationA Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030288 · Cited by 2,632
Self-citationBortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043445 · Cited by 2,491
Self-citationInhibition of Macroautophagy Triggers Apoptosis
Boya, P., González-Polo, R.-A., Casares, N., Perfettini, J.-L., Dessen, P., Larochette, N., Métivier, D., Meley, D., Souquere, S., Yoshimori, T., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1025-1040.2005 · Cited by 1,625
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress & Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,404
Metadata
- Authors
- Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., Munshi, N. C., Richardson, P. G., Hideshima, T., & Anderson, K. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 22
- Pages
- 14374-14379
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1980471295
- Cited by
- 741
- References
- 55
- FWCI
- 23.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.